News Medtech industry closely watching Section 232 investigationHealthradar24. Oktober 2025 Medtech companies are closely watching a new development that could affect tariff rates across the industry. After a summer of…
News MDMA warns Section 232 tariffs could hurt US medtech manufacturingHealthradar21. Oktober 2025 Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:…
News AdvaMed calls for series of trade actions in response to Section 232 probeHealthradar20. Oktober 2025 Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. AdvaMed outlined…
News Section 232 probe reignites tariff uncertainty for medtech firmsHealthradar26. September 2025 Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Medtech companies…
